Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome
Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...
Main Authors: | S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova |
---|---|
格式: | Article |
語言: | Russian |
出版: |
«FIRMA «SILICEA» LLC
2004-12-01
|
叢編: | Российский кардиологический журнал |
主題: | |
在線閱讀: | https://russjcardiol.elpub.ru/jour/article/view/2326 |
相似書籍
-
EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
由: S. V. Nedogoda, et al.
出版: (2016-01-01) -
ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
由: P. P. Tikhonov, et al.
出版: (2015-12-01) -
Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
由: S. V. Nedogoda, et al.
出版: (2005-06-01) -
Workplace arterial hypertension: potential of rilmenidine-based combination therapy
由: S. I. Drozdetsky, et al.
出版: (1970-01-01) -
Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
由: A. P. Kondrakhin, et al.
出版: (2005-10-01)